From the publishers of JADPRO
Multiple Myeloma
Resource Center
Menu
Resources
Videos
Videos
Quizzes
News & Literature Highlights
Case Studies
Advertisement
Test your knowledge of relapsed multiple myeloma treated with teclistamab
Last Updated: Thursday, June 12, 2025
Loading...
Advertisement
News & Literature Highlights
Nature Reviews. Clinical Oncology
EHA-EMN Evidence-Based Guidelines for diagnosis, treatment and follow-up of patients with multiple myeloma
Discover Oncology
Deciphering and targeting oncogenic pathways through integrated approaches and amino acid metabolism in hematologic malignancies
The Journal of the American Academy of Orthopaedic Surgeons
Influence of chimeric antigen receptor T-cell therapy on fracture risk of patients with multiple myeloma
Cancer Nursing
Dynamic changes in symptom clusters and symptom networks in patients with multiple myeloma: Across-lagged network analysis
Clinical Lymphoma, Myeloma & Leukemia
Practical guidance on the clinical management of belantamab mafodotin for patients with relapsed/refractory multiple myeloma: Recommendations from the Middle East and North Africa expert panel
Future Oncology
Community hematologist/oncologist perspectives on minimal residual disease testing in patients with multiple myeloma
International Journal of Molecular Sciences
Breaking barriers: The role of the bone marrow microenvironment in multiple myeloma progression
HemaSphere
Early peripheral blood and bone marrow MRD as prognostic markers in quadruplet-treated multiple myeloma without transplant
Nature Cancer
ISB 2001 trispecific T cell engager shows strong tumor cytotoxicity and overcomes immune escape mechanisms of multiple myeloma cells
ASCO 2025
DREAMM-8 study of belantamab mafodotin plus pomalidomide and dexamethasone vs pomalidomide plus bortezomib and dexamethasone in relapsed/refractory multiple myeloma: A subgroup analysis in patients with high-risk cytogenetic features
Advertisement
Case Studies
Linvoseltamab in Relapsed/Refractory Multiple Myeloma
Relapsed Multiple Myeloma Treated with Teclistamab
Treatment of Intermediate Risk Smoldering Myeloma
Advertisement
Quizzes
Test your knowledge of linvoseltamab in relapsed/refractory multiple myeloma
Test your knowledge of relapsed multiple myeloma treated with teclistamab
Test your knowledge on intermediate risk smoldering multiple myeloma